Trulieve: Analysts Expect US$221 Million In Q3 Revenues

Trulieve (CSE: TRUL) announced that they will be reporting their third quarter financials before the market opens on November 15th.

Analysts have a consensus C$84.53 12-month price target on the company, via a total of 17 analysts, representing an upside of 118%. 5 analysts have strong buy ratings, and the other 12 have buy ratings on the company. The street high comes from Stifel-GMP with an C$135 price target, and the lowest target is a C$54 price target.

14 analysts have revenue estimates for the third quarter. The mean between all 14 is US$221.01 million; this number has been revised slightly down from US$228.46 million at the start of May. The street high is US$2224.40 million while the lowest sits at US$216.15 million.

10 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 65.90%, with this number being revised down from 70.13% at the start of May. Street high is 68% estimate and the lowest sits at 63.50%.

Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$89.35 million, with this number being revised down from US$99.88 million at the start of May. Street high sits at US$97 million EBITDA and the lowest being a US$781.2 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Canaccord Reiterates $1.75 Price Target For Mind Medicine Following Roadshow Event

This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from...

Monday, September 28, 2020, 11:02:24 AM

Boeing Sees Canaccord Reiterate Price Target, Buy Rating

In the last weeks, Boeing (NYSE: BA) has been in the news due to its...

Wednesday, July 21, 2021, 02:13:00 PM

Senate Goes Blue: The Cannabis Analyst Take

Two days ago, Georgia had its senate runoffs to effectively decide which party would have...

Thursday, January 7, 2021, 11:51:00 AM

Hexo: Canaccord Raises Price Target To $9.50

On March 18th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) reported their fiscal second quarter results....

Sunday, March 21, 2021, 02:29:00 PM

Plug Power: Canaccord Halves Price Target After Q1 Results

On June 22nd, Plug Power (NASDAQ: PLUG) announced their first-quarter results, The company announced net...

Friday, June 25, 2021, 11:42:00 AM